Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility And Safety of Early Discharge After Transfemoral Transcatheter Aortic Valve Implantation The FAST-TAVI Study

NCT02404467 is registered in ClinicalTrials.gov with Institut für Pharmakologie und Präventive Medizin as lead sponsor.

NCT NCT02404467
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02404467 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility And Safety of Early Discharge After Transfemoral Transcatheter Aortic Valve Implantation The FAST-TAVI Study
Lead sponsor
Institut für Pharmakologie und Präventive Medizin
Phase
Observational
Overall status
Completed
Start date
January 31, 2015
Completion date
July 31, 2019
Enrollment
502 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis